Developer of an orally administered particle-based platform designed to prevent diseases from developing viral epidemics in aquaculture. The company's platform utilizes a proprietary RNAi nanoparticle formulation that triggers a cellular reaction to disable the viral infection and delivers the coated nanoparticles via feed or immersion, enabling aquaculture industries to improve resistance against viral diseases that attack shrimp and other aquaculture species.
Developer of an orally administered particle-based platform designed to prevent diseases from developing viral epidemics
Biotechnology
Haifa, Israel
0000000000 0
0000000
g elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam,
0000 000000000
Leuven, Belgium
00As of0000
000.00
00.000000-00-00
00000000000 000.00
0000000
dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliq
000000000000000
Nicholasville, KY
0000As of0000
00000
00000000000000
Add Comparison
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.